H. Junkermann

2.4k total citations
55 papers, 1.8k citations indexed

About

H. Junkermann is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, H. Junkermann has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Cancer Research and 16 papers in Pathology and Forensic Medicine. Recurrent topics in H. Junkermann's work include Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (14 papers) and MRI in cancer diagnosis (12 papers). H. Junkermann is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (14 papers) and MRI in cancer diagnosis (12 papers). H. Junkermann collaborates with scholars based in Germany, United States and Austria. H. Junkermann's co-authors include Hans‐Peter Sinn, I. Zuna, Gunnar Brix, Stefan Delorme, Christof Sohn, Michael V. Knopp, Joerg Heil, G. van Kaick, Michael Golatta and Sarah Schott and has published in prestigious journals such as PLoS ONE, Radiology and Annals of the New York Academy of Sciences.

In The Last Decade

H. Junkermann

53 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Junkermann Germany 20 884 702 406 390 292 55 1.8k
H. Madjar Germany 21 534 0.6× 541 0.8× 297 0.7× 595 1.5× 300 1.0× 76 1.6k
In-Ae Park South Korea 24 627 0.7× 509 0.7× 228 0.6× 476 1.2× 241 0.8× 66 1.5k
Petrina A. Causer Canada 17 1.1k 1.2× 496 0.7× 91 0.2× 581 1.5× 334 1.1× 37 1.9k
Katharina Heusinger Germany 21 232 0.3× 603 0.9× 157 0.4× 260 0.7× 487 1.7× 56 1.2k
Michael Golatta Germany 30 545 0.6× 1.3k 1.9× 420 1.0× 742 1.9× 716 2.5× 133 2.5k
Alana A. Lewin United States 20 488 0.6× 337 0.5× 60 0.1× 282 0.7× 254 0.9× 58 1.2k
R. Schulz-Wendtland Germany 16 423 0.5× 434 0.6× 68 0.2× 350 0.9× 357 1.2× 65 1.2k
Maria Adele Marino Italy 23 975 1.1× 305 0.4× 97 0.2× 307 0.8× 158 0.5× 61 1.4k
Eun Young Chae South Korea 25 989 1.1× 535 0.8× 66 0.2× 488 1.3× 310 1.1× 112 1.7k
Inge Marie Obdeijn Netherlands 8 705 0.8× 540 0.8× 123 0.3× 565 1.4× 443 1.5× 11 1.6k

Countries citing papers authored by H. Junkermann

Since Specialization
Citations

This map shows the geographic impact of H. Junkermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Junkermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Junkermann more than expected).

Fields of papers citing papers by H. Junkermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Junkermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Junkermann. The network helps show where H. Junkermann may publish in the future.

Co-authorship network of co-authors of H. Junkermann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Junkermann. A scholar is included among the top collaborators of H. Junkermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Junkermann. H. Junkermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verhoeven, Didier, Claudia Allemani, Pankaj G. Roy, et al.. (2024). High-value breast cancer care within resource limitations. The Oncologist. 29(7). e899–e909. 3 indexed citations
2.
Ćuk, Katarina, Manuela Zucknick, Joerg Heil, et al.. (2012). Circulating microRNAs in plasma as early detection markers for breast cancer. International Journal of Cancer. 132(7). 1602–1612. 211 indexed citations
3.
Heil, Joerg, Ádám Gondos, Geraldine Rauch, et al.. (2012). Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. The Breast. 21(3). 303–308. 35 indexed citations
4.
Heil, Joerg, et al.. (2012). Detected, yet not Diagnosed Breast Cancer Screening with MRI Mammography in High-Risk Women. Breast Care. 7(3). 236–239. 3 indexed citations
5.
Heil, Joerg, Michael Golatta, Joachim Rom, et al.. (2011). Does a Supplementary Preoperative Breast MRI in Patients with Invasive Lobular Breast Cancer Change Primary and Secondary Surgical Interventions?. Annals of Surgical Oncology. 18(8). 2143–2149. 24 indexed citations
6.
Heil, Joerg, Anna Maria Buehler, Michael Golatta, et al.. (2011). Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?. Annals of Oncology. 23(1). 98–104. 32 indexed citations
7.
Becker, Nikolaus & H. Junkermann. (2008). Benefit and Risk of Mammography Screening. Considerations from an Epidemiological Viewpoint. Deutsches Ärzteblatt international. 105(8). 131–6. 9 indexed citations
8.
Junkermann, H.. (2007). Indikationen und Kontraindikationen kontrastmittelverstärkter MRT- und CT-Untersuchungen in der Schwangerschaft. Der Radiologe. 47(9). 774–777. 4 indexed citations
9.
Junkermann, H., et al.. (2005). Influence of different HRT regimens on mammographic density. Maturitas. 50(2). 105–110. 16 indexed citations
10.
Wasser, K., Saskia K. Klein, H. Junkermann, et al.. (2005). Neoadjuvante Chemotherapie des Mammakarzinoms. Der Radiologe. 47(5). 421–429. 4 indexed citations
11.
Wasser, K., Saskia K. Klein, Christine Fink, et al.. (2003). Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. European Radiology. 13(1). 80–87. 78 indexed citations
12.
Knopp, Michael V., Jannis Radeleff, H. Junkermann, et al.. (2002). Methodenvergleich zur Quantifizierung der Kontrastmittelanreicherung am Beispiel der dynamischen MR-Mammographie. Der Radiologe. 42(4). 280–290. 6 indexed citations
13.
Minckwitz, Gϋnter von, Serban Dan Costa, Kay Friedrichs, et al.. (2002). Evidence-Based Recommendations on Primary Treatment of Carcinomas of the Breast. Zentralblatt für Gynäkologie. 124(5). 293–303. 8 indexed citations
14.
Knopp, Michael V., Elisa K. Weiß, Hans‐Peter Sinn, et al.. (1999). Pathophysiologic basis of contrast enhancement in breast tumors. Journal of Magnetic Resonance Imaging. 10(3). 260–266. 301 indexed citations
15.
Knopp, Michael V., I. Zuna, H. Junkermann, et al.. (1998). Multi-reader-analysis to assess functional MR-Mammography. Der Radiologe. 38(4). 307–314. 5 indexed citations
16.
Junkermann, H. & D. von Fournier. (1997). Imaging procedures for assessment of the response of mammary carcinoma to preoperative chemotherapy. Der Radiologe. 37(9). 726–732. 12 indexed citations
17.
Heß, Thomas, Małgorzata Knapp, Udo Hoffmann, et al.. (1994). Pharmakokinetische Analyse der Gd-DTPA-Anreicherung in der MRT beim Mammakarzinom. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 160(6). 518–523. 14 indexed citations
18.
Knopp, M.V., Gunnar Brix, H. Junkermann, & Hans‐Peter Sinn. (1994). MR MAMMOGRAPHY WITH PHARMACOKINETIC MAPPING FOR MONITORING OF BREAST CANCER TREATMENT DURING NEOADJUVANT THERAPY. Magnetic Resonance Imaging Clinics of North America. 2(4). 633–658. 101 indexed citations
19.
Huber, S, Stefan Delorme, Michael V. Knopp, et al.. (1994). Breast tumors: computer-assisted quantitative assessment with color Doppler US.. Radiology. 192(3). 797–801. 77 indexed citations
20.
Ludwig, H., et al.. (1971). Oberfl�chenstrukturen der menschlichen Placenta im Rasterelektronenmikroskop. Archives of Gynecology and Obstetrics. 210(1). 1–20. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026